Compound 799
Identifiers
- Canonical SMILES:
CN[C@@H](C)C(=O)N[C@@H](C1CCOCC1)C(=O)N1CCC[C@H]1c1cc2ccnc(-c3ccccc3Cl)c2[nH]1
- IUPAC name:
(2S)-N-[(1S)-2-[(2R)-2-[7-(2-chlorophenyl)-1H-pyrrolo[2,3-c]pyridin-2-yl]pyrrolidin-1-yl]-1-(oxan-4-yl)-2-oxoethyl]-2-(methylamino)propanamide
- InChi:
InChI=1S/C28H34ClN5O3/c1-17(30-2)27(35)33-25(18-10-14-37-15-11-18)28(36)34-13-5-8-23(34)22-16-19-9-12-31-26(24(19)32-22)20-6-3-4-7-21(20)29/h3-4,6-7,9,12,16-18,23,25,30,32H,5,8,10-11,13-15H2,1-2H3,(H,33,35)/t17-,23-,25-/m0/s1
- InChiKey:
VBAQGNWLWUEVKO-XPEQFSOGSA-N
External links
68237999 |
External search
Bibliography (1)
Publication | Name |
---|---|
Philippe Bergeron, Michael F. T. Koehler, Genentech, Inc.. . Azaindole inhibitors of iap None. | 11 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
XIAP / Smac | 6.92 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 523.24 g/mol | |||
HBA | 8 | |||
HBD | 3 | |||
HBA + HBD | 11 | |||
AlogP | 2.65 | |||
TPSA | 99.35 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2010021934 | 11 | XIAP P98170 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.17 | |
WO2010021934 | 11 | XIAP P98170 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.92 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5275 | Velpatasvir | DB11613 | |
0.5240 | Ravidasvir | DB15652 | |
0.5167 | Samatasvir | DB12660 | |
0.5069 | Delanzomib | DB11956 | |
0.5046 | CP-320626 | DB03383 | |
0.4977 | Daclatasvir | DB09102 | |
0.4942 | Ledipasvir | DB09027 | |
0.4894 | Eluxadoline | DB09272 | |
0.4892 | Odalasvir | DB13041 | |
0.4888 | Yohimbine | DB01392 | |
0.4884 | Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate | DB03744 | |
0.4864 | 1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one | DB08738 | |
0.4844 | N,N-[2,5-O-dibenzyl-glucaryl]-DI-[valinyl-aminomethanyl-pyridine] | DB03803 | |
0.4842 | Indinavir | DB00224 | |
0.4766 | Nemorexant | DB15031 |